Randomized phase II – study evaluating EGFR targeting therapy with Cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer...

por Krempien, R, Muenter, MW, Huber, PE, Nill, S, Friess, H, Timke, C, Didinger, B, Buechler, P, Heeger, S, Herfarth, KK, Abdollahi, A, Buchler, MW, Debus, J
Publicado 2005

Treatment of non-small cell lung cancer with intensity-modulated radiation therapy in combination with cetuximab: the NEAR protocol (NCT00115518)

por Jensen, AD, Münter, MW, Bischoff, H, Haselmann, R, Timke, C, Krempien, R, Sterzing, F, Nill, S, Heeger, S, Hoess, A, Haberkorn, U, Huber, PE, Steins, M, Thomas, M, Debus, J, Herfarth, KK
Publicado 2006

The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with...

por Klement, Rainer J., Abbasi-Senger, N., Adebahr, S., Alheid, H., Allgaeuer, M., Becker, G., Blanck, O., Boda-Heggemann, J., Brunner, T., Duma, M., Eble, M. J., Ernst, I., Gerum, S., Habermehl, D., Hass, P., Henkenberens, C., Hildebrandt, G., Imhoff, D., Kahl, H., Klass, N. D., Krempien, R., Lewitzki, V., Lohaus, F., Ostheimer, C., Papachristofilou, A., Petersen, C., Rieber, J., Schneider, T., Schrade, E., Semrau, R., Wachter, S., Wittig, A., Guckenberger, M., Andratschke, N.
Publicado 2019